Literature DB >> 24611208

International Conference on Harmonisation; E2B(R3) Electronic Transmission of Individual Case Safety Reports; Data Elements and Message Specification; Appendix on Backwards and Forwards Compatibility; availability. Notice.

.   

Abstract

The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "E2B(R3) Electronic Transmission of Individual Case Safety Reports (ICSRs): Implementation Guide--Data Elements and Message Specification'' (the E2B(R3) implementation guidance) and an appendix to the guidance entitled "ICSRs: Appendix to the Implementation Guide--Backwards and Forwards Compatibility'' (the BFC appendix). The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The E2B(R3) implementation guidance is intended to revise the standards for submission of ICSRs and improve the inherent quality of the data, enabling improved handling and analysis of ICSR reports. The BFC appendix describes the relationship between data elements from the 2001 ICH E2B guidance and the E2B(R3) implementation guidance.

Entities:  

Mesh:

Year:  2014        PMID: 24611208

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.

Authors:  Kaori Nomura; Kunihiko Takahashi; Yasushi Hinomura; Genta Kawaguchi; Yasuyuki Matsushita; Hiroko Marui; Tatsuhiko Anzai; Masayuki Hashiguchi; Mayumi Mochizuki
Journal:  Drug Des Devel Ther       Date:  2015-06-12       Impact factor: 4.162

2.  Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth.

Authors:  Diego Macías Saint-Gerons; Sheila Rodovalho; Ádila Liliane Barros Dias; André Lacerda Ulysses de Carvalho; Andrea Beratarrechea; Wuelton Marcelo Monteiro; Myrna Barata Machado; Cristiano Fernandes da Costa; Marcelo Yoshito Wada; Márcia Helena Maximiano Faria de Almeida; Rayanne Silva de Matos Fonseca; Jady Shayenne Mota Cordeiro; Alinne Paula Rodrigues Antolini; João Altecir Nepomuceno; Karen Fleck; Fernanda Simioni Gasparotto; Marcus Lacerda; Robin Rojas-Cortés; Shanthi Narayan Pal; Analía I Porrás; María de la Paz Ade; José Luis Castro
Journal:  Malar J       Date:  2022-01-29       Impact factor: 2.979

3.  Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience.

Authors:  Vivekanandan Kalaiselvan; Shatrunajay Shukla; Shubhang Arora; Tarani Prakash Shrivastava; Rajeev Singh Raghuvanshi
Journal:  Front Public Health       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.